Announcements Trials
Browse Landscape

Phase

Phase 1/2 5Phase 2 4Phase 1 4Phase EARLY_PHASE1 2

Status

Completed 12Recruiting 10Unknown 5Not yet recruiting 5Active not recruiting 2Terminated 1Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Breast Neoplasms 24Carcinoma, Non-Small-Cell Lung 20Neoplasms 19Colorectal Neoplasms 19Recurrence 17Pancreatic Neoplasms 17Multiple Myeloma 15Advanced Solid Tumors 13Prostatic Neoplasms 12Advanced Solid Tumor 12Stomach Neoplasms 10Ovarian Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Triple Negative Breast Neoplasms 8Neoplasm Metastasis 7Melanoma 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Solid Tumor 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Endometrial Neoplasms 5

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Solid Tumors × Clear all
NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

GlaxoSmithKline

Phase 1/2 Not yet recruiting
184 enrolled
Other solid neoplasm

Solid Tumors

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

RemeGen Co., Ltd.

Phase 1/2 Not yet recruiting
326 enrolled
Other solid neoplasm

Solid Tumors

NCT06955390 2025-05-02

Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

Henan Cancer Hospital

Phase 1/2 Not yet recruiting
32 enrolled
Other solid neoplasm

Solid Tumors

NCT06947226 2025-04-27

A Clinical Study of 9MW2821 Monotherapy or Combined With Other Anticancer Therapy in Advanced Solid Tumors

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 1/2 Not yet recruiting
188 enrolled
Other solid neoplasm

Solid Tumors

NCT06928363 2025-04-15

A First-in-human Study of KY-0301 in Patients With Advanced Solid Tumors.

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Phase 1/2 Not yet recruiting
212 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡